Equitable Holdings arrives at its August 5 print with a notable shift underway: short sellers who spent most of July covering are now rebuilding positions at the fastest weekly pace in months.
Short interest has jumped 27% over the past week to 2.2% of the free float — reversing a month-long covering trend that had pushed it below 2%. The one-day move alone on August 3 was 15%. That said, the absolute level remains modest, and the lending market offers no friction to this rebuild: availability is extraordinarily loose at 4,760% of outstanding short interest, with borrow costs running below 0.4%. New shorts face no squeeze risk. The ORTEX short score has edged higher in recent sessions, reaching 31.1 on August 3 — a gentle upward drift rather than an alarm signal.
Options positioning reinforces the bullish lean, standing in contrast to the short-side rebuild. The put/call ratio has fallen to 0.95, now running 1.6 standard deviations below its 20-day mean of 1.51 — a continuation of the sharp pivot toward calls that was already evident in the prior preview. This is a meaningful departure from the defensive hedging that dominated positioning through June and early July, when the PCR ran above 1.8. Peers JXN and both gained more than 4% on the week, while EQH slipped 2.3% to $48.25 — a divergence that leaves the stock looking relatively cheap within the group heading into the release.
The analyst community has been one of the most uniformly bullish in the sector. Every major firm that updated in early July raised its price target: UBS moved to $68, Jefferies to $66, Evercore ISI to $65, with Keefe Bruyette and Mizuho at $62. The mean target of $60.82 implies roughly 26% upside from current levels — a gap that barely budged through July's rally. The EPS surprise factor score ranks in the 83rd percentile, so the company has a consistent track record of beating. The lone dissent remains Barclays at $50, and insiders have been selling steadily — the CEO sold nearly $1.9 million worth of stock on July 20, the COO sold approximately $700,000 on July 15, and net insider activity over 90 days totals more than $8.2 million in sales. That insider selling pattern, against a backdrop of unanimous analyst upgrades, is the central tension the print must resolve.
The August 5 report is therefore a test of whether EQH's operating momentum can justify closing the persistent gap between price and analyst targets — or whether the recent insider selling and short-side rebuilding reflect an information advantage the Street's optimism has yet to price in.
See the live data behind this article on ORTEX.
Open EQH on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
Equitable Holdings heads into its July 30 earnings release with the Street firmly in its corner — but the stock is trading well below where analysts think it should be. The analyst consensus heading into the print is…
EQH enters earnings season with its sharpest monthly rally in recent memory — up 15% over 30 days to $46.98 — and fresh analyst conviction behind it, yet insiders have been cashing out consistently as the price…
